Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Total gain-$4,873.80(99.19%)
Still waiting for the 2 for 1 split we were promised. Either way Nobody's going to even trust these bums ever again even if they change there name.
sother stock sales....Dumping
Newstead Jennifer
CLO
Uninformative Sell
$54,802.08
6 days ago
Newstead Jennifer
CLO
Uninformative Sell
$55,568.16
13 days ago
Newstead Jennifer
CLO
Uninformative Sell
$119,958.39
21 days ago
Newstead Jennifer
CLO
Uninformative Sell
$1,473,060.50
21 days ago
sother stock sales....Dumping
Newstead Jennifer
CLO
Uninformative Sell
$54,802.08
6 days ago
Newstead Jennifer
CLO
Uninformative Sell
$55,568.16
13 days ago
Newstead Jennifer
CLO
Uninformative Sell
$119,958.39
21 days ago
Newstead Jennifer
CLO
Uninformative Sell
$1,473,060.50
21 days ago
Rosenblatt cut the price target on Meta Platforms, Inc. (NASDAQ: META) from $156 to $154. Meta shares rose 0.1% to $158.57 in pre-market trading..
Citing the $10 billion Apple will cost them. And another $10 billion Yr to continue Funding the Meta. Revenue has been cut by 53% since 2020
Going to be cut even more.
They are at war with people on their facebook site.
Due to missinformation scams they post
You don't make Green ... You just steal it from your investors.
No one will ever trust any of you again
Once a thief always a thief
If a class action against strongo and his felon partners . count me in This kind of SCUM deserves To be Banned from any penny stock and needs to pay restitution before his execution
Strongo. watch your Baby go sub penny. IDIOT
Chart tells it all. Buying up heavily before 30th. Then split never happened. They scammed you all .Pump and dump on a 2/1 split.. Lying scum these Bastards. Take their homes and auction off the Patents to pay us all back
Chart tells it all. Buying up heavily before 30th. Then split never happened. They scammed you all .Pump and dump on a slit.. Lying scum these Bastards. Take their homes and auction off the Patents to pay us all back
Company said.
News Article
Global Wholehealth Partners Corporation Declares Special Common Stock Dividend
6:00am ET 1/13/2022 Globe Newswire
via NewMediaWire -- On January 13, 2022, Global Wholehealth Partners Corporation (the "Company") (OTC: GWHP) announced today that its Board of Directors declared a special one-time dividend of two shares of common stock for each one share of common stock of the Company, payable on April 1, 2022, to the shareholders of record at the close of business on March 31, 2022..
4/5/22 still waiting for this scam to deliver on it's promise
The referenced stock split is still unconfirmed with our custodian. I see that an Ex-Date has not been ruled as of yet. Once an ex-date is ruled, the shares will split on that date
The Split must be Pump and Dump Plot
Still waiting for my Split. Does someone need Bail to make this happen
Latest news said It was a 3 for 1 split. so 3x0 = 0 can't wait 36 000 of 0 equals the same Because ZERO is what were getting after lawsuit is over. F***ing zip
Global WholeHealth Partners Stock Scheduled to Split on Wednesday, March 30th (OTCMKTS:GWHP)
Posted by MarketBeat News on Mar 14th, 2022
Global WholeHealth Partners logoShares of Global WholeHealth Partners Co. (OTCMKTS:GWHP – Get Rating) are set to split before the market opens on Wednesday, March 30th. The 3-1 split was announced on Wednesday, March 30th. The newly issued shares will be issued to shareholders after the market closes on Wednesday, March 30th.
Shares of OTCMKTS:GWHP opened at $0.03 on Monday. The firm has a 50 day moving average of $0.06 and a 200-day moving average of $0.17. Global WholeHealth Partners has a 12 month low of $0.02 and a 12 month high of $0.94.
Get Global WholeHealth Partners alerts:
Enter Your Email Address
About Global WholeHealth Partners (Get Rating)
Global WholeHealth Partners Corporation manufactures and markets various in vitro diagnostic test kits in the United States. It offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as point-of-care, which includes hospitals, physicians' offices, and medical clinics.
Defendants
Brian Vomer, 58, of Carson City, Nevada
Joshua Yafa, 47, of Boca Raton, Florida
Jamie Yafa, 43, of Kissemmee, Florida
Charles Strongo, 58, of San Clemente, California
Carl Marciniak, 57, of Minden, Nevada
All five men face conspiracy and securities fraud charges and could spend up to 20 years in prison if convicted.
Stock promotion. If you stay in you will get 2 for 1 stock split. so if you went to school you would know 2x0 = 0 Incentive to double down. They can't even show their new display.I know I asked to see it as one of my Trades was display's printing and Diecutting. So it was all bullshit
Stock promotion. If you stay in you will get 2 for 1 stock split. so if you went to school you would know 2x0 = 0 Incentive to double down. They can't even show their new display.I know I asked to see it as one of my Trades was display's printing and Diecutting. So it was all bullshit
Been in a few failed pennies. They thought they were above the law. They made posts to drive up the product. In RMCP the product after 15 years of bullshit was Unfit for human Use. The officers were all guilty of Fraud. The fines were excessive and company went belly up. Strongo has made claims about products that were not true. There are over 150 charges against him and the company and it's officers all involved in a pump and dump scheme
Hope your having a fun time with My money Strongo. Better save some for Lube in the coming months in Jail
Correct this is a total Fraud. Seen this before and been a part of a few.
TTRIF RMCP and a few others. This is the end of Strongo and his cronies.
Down about $5k and hope the SEC (class action) against him gives us some relief.
What a peice of Low Life DIRT
I took a position thinking this would likely run but with OTC's you never know. If you are interested this would be a good entry point. I averaged instead of waiting. I may pick up another 10 k in the next week or so.I went from selling BTZI at 17 cents to here. I rarely do OTC's but seemed like a possible winner with time. will see in a year as to where it goes seems they are making headway into the box stores/ internet sales
Yes if you don't take the profit. But there again I thought the 40 cents would hold
A new effort to keep the investors
News Article
Global Wholehealth Partners Corporation Declares Special Common Stock Dividend
6:00am ET 1/13/2022 Globe Newswire
via NewMediaWire -- On January 13, 2022, Global Wholehealth Partners Corporation (the "Company") (OTC: GWHP) announced today that its Board of Directors declared a special one-time dividend of two shares of common stock for each one share of common stock of the Company, payable on April 1, 2022, to the shareholders of record at the close of business on March 31, 2022.
About Global Wholehealth Partners Corporation
The Company's executive offices are located in San Clemente, California with manufacturing, warehousing and laboratories in San Diego and Oceanside California. The Company was founded to develop, manufacture and market in vitro diagnostic (IVD) tests for over-the-counter (OTC or consumer), and point-of-care (POC or professional) use markets. The Company currently manufactures and markets a range of diagnostic test kits for consumer use through over-the-counter (OTC) sales, and for use by health care professionals, generally located at medical clinics, physician offices and hospitals known as Points-of-Care (POC), in the United States. These test kits are known as in vitro diagnostic test kits or "IVD" products. GWHP has evolved into a leading Health Care company by expanding itself from diagnostic products to the full service health care company. GWHP has partnered with several companies in the health care industry which broaden the scope of GWHP business, giving GWHP a strong controlling vertical and horizontal integration in the health care industry.
Media Contact:
Name: Charles Strongo,
I would think that was to the JV they tried to set up in Indonesia that Just seemed to vanish, Probably along with the revenue. been waiting for any news on the sales from walimart and shopify ETC. so far Nothing Nada and with the stock price in the toilet I would have expected some effort to stabilize the price
If this Package display is so important. SHOW ME Your Display show your Investors the Display. Prices are increasing for Product and we should be out there. Please no more excuses for covid. As for printing and die cutting that should not be any problem.
Ready to go to market 11/30 . with the best market display's. No body cares about the display... they Just want the tests. They want them Now Now Now.
Unfortuatly the Bus plan when looking up seems very poor. Mr Strongo has been working this for 9 years. I hope he has the ability to pull this company back from the edge and move us to Profitability. The news sounds good But the Chart is just plain Ugly.
Well You haven't got that far to fall to be 100%. Myself down 90%
I really hope you can follow through with the plan and put some new hope out with the big box stores
PERFORMANCE
5 Day
-36.92%
1 Month
-50.90%
3 Month
-72.58%
YTD
-88.55%
1 Year
-90.12%
RECENT NEWS
MARKETWATCH
DOW JONES
No Headlines Available
OTHER NEWS
PRESS RELEASES
No Headlines Available
GLOBAL WHOLEHEALTH PARTNERS CORP.
Global Wholehealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.
News Article and it's about time
Global WholeHealth Partners Corp.'s (OTC: GWHP) Newly Designed Tests Are Now Ready for the Launch Into the Retail Marketplace and is Ready to Start the Sales to the Online Companies Approved as Stated in the 8K Filing 08/03/2021
7:00am ET 11/30/2021 Globe Newswire
Global WholeHealth Partners Corp. (OTC:GWHP) is presenting 5 OTC (Over the Counter) products to be sold in the retail marketplace. See the New designs.
via NewMediaWire -- Global is planning on selling the Pregnancy, Ovulation, Drug Tests, Glucose, and Colorectal Cancer Tests to start the retail marketing. Global knows that it only gets one chance to show well, so it has spent several weeks with graphic artists and marketing designers to make sure Global's first impression is amazing.
News Article
Global WholeHealth Partners Corp (OTC: GWHP) Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market; 8k Filed on 09/21/2021
7:00am ET 9/29/2021 Globe Newswire
Global WholeHealth Partners Corp (GWHP) is confident in the new partnerships to produce the best COVID Antigen test on the market.
via NewMediaWire -- COVID Antigen testing is not going away and has become the new test and vaccine for years to come.
Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest lines of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses. The strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein. Global understands the need to be ahead of the virus to conquer the virus. Now, with the vaccine, Global is offering one of the largest lines of products to fight this virus.
Global understands that this is a war on COVID 19 and we are expanding our line of products to be able to fight. With a facility now in the Philippines, Global will be able to fight the COVID War better by taking the fight to some of the regions of the world which have not been serviced.
Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.
With results in minutes versus hours or days with other diagnostic kits, the more lives that can be saved with the only FDA authorized COVID-19 POC serology Point of Care Test. With the new fingerstick test, healthcare providers can prick a patient's finger and get results in minutes without having to wait for venous blood. Global WholeHealth Partners will be able to distribute these tests to more urgent cares, hospitals, and - to help curb the spread of CoViD19 SARS2.
As a third surge of the coronavirus threatens much of the United States, public health experts across the country say there still aren't enough tests available to keep the virus under control. With the continual mutation of the virus, Global is keeping up with demand and keeping up with the continual changes of the virus in the R & D of the tests.
Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases FDA Certificate of Exportability (2260-11-2019). The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.
GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians' offices, and medical clinics in the US and abroad. Notably, Global offers 56 products FDA approved and many are Approved for OTC use, and 25 POC products approved by the FDA.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.
Media Contact:
Name: Charles Strongo,
Seems you did. Unlike myself Been here in the house of pain
Has anyone seen any covid or other tests displayed in walmart from GWHP It's been about 3 months I believe since post
we would appreciate some news on sales on these Multi Billion dollar sites you have listed in the news feed .
News Article
Global WholeHealth Partners Corp (OTC: GWHP) Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market; 8k Filed on 09/21/2021
7:00am ET 9/29/2021 Globe Newswire
Global WholeHealth Partners Corp (GWHP) is confident in the new partnerships to produce the best COVID Antigen test on the market.
via NewMediaWire -- COVID Antigen testing is not going away and has become the new test and vaccine for years to come.
Global WholeHealth Partners Corp. (OTC: GWHP) offers one of the largest lines of COVID 19 tests. Global WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer are capable of detecting all the current identified SARS-CoV-2 viruses. The strains identified in the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) strain contains multiple mutations, most reflected in the S gene, which encodes the spike protein. Global understands the need to be ahead of the virus to conquer the virus. Now, with the vaccine, Global is offering one of the largest lines of products to fight this virus.
Global understands that this is a war on COVID 19 and we are expanding our line of products to be able to fight. With a facility now in the Philippines, Global will be able to fight the COVID War better by taking the fight to some of the regions of the world which have not been serviced.
Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.
With results in minutes versus hours or days with other diagnostic kits, the more lives that can be saved with the only FDA authorized COVID-19 POC serology Point of Care Test. With the new fingerstick test, healthcare providers can prick a patient's finger and get results in minutes without having to wait for venous blood. Global WholeHealth Partners will be able to distribute these tests to more urgent cares, hospitals, and - to help curb the spread of CoViD19 SARS2.
As a third surge of the coronavirus threatens much of the United States, public health experts across the country say there still aren't enough tests available to keep the virus under control. With the continual mutation of the virus, Global is keeping up with demand and keeping up with the continual changes of the virus in the R & D of the tests.
Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases FDA Certificate of Exportability (2260-11-2019). The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.
GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians' offices, and medical clinics in the US and abroad. Notably, Global offers 56 products FDA approved and many are Approved for OTC use, and 25 POC products approved by the FDA.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.
Media Contact:
Name: Charles Strongo,
boost for testing strips dengay and other tests
https://www.msn.com/en-us/news/us/climate-change-lets-mosquitoes-flourish-and-feast-in-los-angeles/ar-AAOBjrQ?ocid=msedgntp
Global WholeHealth Partners Corp (OTC:GWHP), Gains Approval in the Ability to Sell Through Shopify's Multibillion Dollar Online Platform as Stated in 8k Filing 08/05/21
7:00am ET 9/7/2021 Globe Newswire
via NewMediaWire - Global WholeHealth Partners Corp (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests, announces approval to open an online store with Shopify's multibillion dollar online platform.
With 44 million active buyers, Shopify's online store offers Global Wholehealth Partners Corporation a massive potential for broad visibility for its line of over-the-counter tests, including pregnancy, ovulation, drug, colorectal cancer, and glucose. Because of the unique platform of Shopify, Global will be able to sell both OTC and Professional Tests online.
"Gaining the approval for this deal with the Shopify could prove to be very lucrative for Global Wholehealth Partners and its shareholders as this could potentially put us in right front of a massive audience of active buyers," said Charles Strongo, CEO of Global WholeHealth Partners Corp (OTC: GWHP). Global has now been approved and is preparing the marketing and design to be on Walmart Online, Amazon, Ebay Market and Shopify. The retail industry has moved to online and now Global is covering all the major players in the online segment.
"The Drug Testing Market alone is expected to be almost $12 Billion per year by 2028," Strongo stated.
"The Pregnancy Testing and Ovulation Testing Markets are also showing signs of consistent steady growth," reiterated Strongo.
Drug Testing Market Size is expected to be worth $11.7 Billion By 2028
In a press release published by Grand View Research, Inc. on May 31, 2021, below, their report states that the Drug Testing Market Size is expected to be worth $11.7 Billion by 2028 with a CAGR of 4.9%. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.
Drug Testing Market Size Worth $11.7 Billion By 2028 | CAGR: 4.9%: Grand View Research, Inc. (prnewswire.com)
The Global Pregnancy Testing Market Size is Estimated to be Worth $1.74 Billion by 2026
According to a recent report by Market Data Forecast, the global pregnancy testing market size is estimated to be worth $1.36 Billion in 2021. Furthermore, it is forecasted to grow to $1.74 Billion by 2026, growing at a CAGR of 5.10%.
Pregnancy Testing kits are medical devices that are used to identify early signs of pregnancy in women. The device detects a little HCG (Human Chorionic Gonadotropin; female pregnancy hormone), which grows within the human body during the early weeks of development. The level of HCG in the blood doubles every 2 to 3 days in the early days of pregnancy, indicating that the pregnancy is progressing. Thus, the presence of HCG over a certain level indicates pregnancy. Testing kits are widely used in families, gynecological clinics, and hospitals.
Pregnancy Testing Market Size, Growth Analysis Report | 2021 to 2026 (marketdataforecast.com)
The Ovulation Test Market Expected to Reach $230.6 Million by 2027
As stated in a press release published by 360 Research Report and distributed to MarketWatch on June 14, 2021, seen here, the Ovulation Test Market is expected to reach $230.6 Million by 2027 at CAGR 4%.
An Ovulation Home Test Kit is used by women. It helps determine the time in the menstrual cycle when getting pregnant is most likely. The test detects a rise in luteinizing hormone (LH) in the urine. A rise in this hormone signals the ovary to release the egg.
Ovulation Test Market to Reach USD 230.6 mn by 2027 at CAGR 4%, as Major Key Contributors to the Market Growth | 360 Research Report - MarketWatch
The US market alone is estimated at 20 million pregnancy and ovulation tests per year.
"Even as we seem to be doing more than our fair share in fighting the COVID-19 Pandemic with our Rapid Test kits for detecting Coronavirus and our new deals to sell and distribute vaccines from the Big 4, we are still a Diagnostics Company at heart and we're very excited for what the future holds for us with our new deals with the Amazon, Walmart, Ebay Marketplace and Shopify," said in closing by Charles Strongo, CEO of Global WholeHealth Partners Corp (OTC: GWHP).
Global WholeHealth Partners Corp. (OTC: GWHP) provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases with an FDA Certificate of Exportability (2260-11-2019). The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.
GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians' offices, and medical clinics in the US and abroad. Currently, the Company has 70 products FDA approved and many are approved for OTC use, and 29 POC products approved by the FDA CLIA WAIVED.
Call or email about special prices for this announcement on all the tests.